NLS Intellectual Property

NextCell Pharma has announced the issuance of a US patent titled “MSC Prediction Algorithm” by the United States Patent and Trademark Office (USPTO).

The US Patent and Trademark Office (USPTO) has granted Prolight a patent for the analytical unit and reaction chamber for the company’s point-of-care analysis system, MicroFlex, which is being developed by Prolight’s partner TTP (The Technology Partnership).

Diamyd Medical's patent application protecting the use of insulin-based antigens for the treatment of autoimmune diabetes in patients carrying the HLA DR4-DQ8 genetic marker will be granted by the European Patent Office (EPO).

The European Patent Office, EPO, has issued a decision to grant European patent for exidavnemab, a drug candidate being developed as a treatment for synucleinopathies such as Parkinson’s disease and Multiple System Atrophy (MSA).

The Unites States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application with claims covering a method of treating rheumatoid arthritis (RA) with resomelagon (AP1189) in combination with methotrexate (MTX).

The company has been granted a patent by the European Patent Office (EPO) for GmPcides, a new class of synthetic antibacterials.